This finding suggests that IDH1 missense mutations occur approximately four times less frequently in genomes with IDH2 mutations compared to genomes without IDH2 mutations, indicating a potential antagonistic relationship or functional redundancy observed in brain tumors [33]. Here, IDH1 is linked to brain neoplasm.